Alterations of the retinoblastoma gene in human prostate adenocarcinoma

Genes Chromosomes and Cancer

Volumn 15, Issue 2, 1996, Pages 108-114

  Tricoli, James V ^a,d   Gumerlock, Paul H ^b   Yao, Joyce L ^a   Chi, Sung Gil ^c   D'Souza, Sharon A ^a   Nestok, Blake R ^a   DeVere White, Ralph W ^c   French, Frank S ^e   Gelmann, Edward P ^f   Pretlow, Thomas G ^g   Stearns, Mark E ^h  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; DENSITOMETRY; EXON; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE ADENOCARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 9044253703     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199602)15:2<108::AID-GCC5>3.0.CO;2-7     Document Type: Article

References (29)

1. Bookstein R, Lee W-H (1991) Molecular genetics of retinoblastoma suppressor genes. CRC Crit. Rev. Oncogenesis 2:211-227.
2. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee W-H (1990a) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Nad Acad Sci USA 87:7762-7766.
3. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H (1990b) Suppression of tumorigenicity of human prostate cells by replacing a mutated RB gene. Science 247:712-715.
4. Boring CC, Squires TS, Tong T, Montgomery S (1994) Cancer statistics CA Cancer J Clin 44:7-26.
5. Brooks JD, Bova GS, Isaacs WB (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. The Prostate 26:35-39.
6. Carter BS, Epstein JI, Isaacs WB (1990) Ras gene mutations in human prostate carcinoma. Cancer Res 50:6830-6832.
7. Carter BS, Ewing CM, Ward JW, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci USA 87:8751-8755.
8. Chi SG, de Vere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH (1994) p53 in prostate cancer: frequently expressed transition mutations. JNCI 86:926-933.
9. Daar IO and Maquat LE (1988) Premature termination mediates trisophosphate isomerase mRNA degradation. Mol Cell Biol 8:802-813.
10. Dunn JM, Phillips RA, Zhu X, Becker A, Gallie BL (1989) Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol 9:4596-4604.
11. Fishman JR, Gumerlock PH, Meyers FJ, DeVere White RW (1994) Quantitation of NM23 expression in human prostate tissues. J. Urology 152:202-207.
12. Gumerlock PH, Poonamallee UR, Meyers FJ, DeVere White RW (1991a) Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 51:1632-1637.
13. Gumerlock PH, Tang YJ, Meyers FJ, Silva J (1991b) Use of polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Inf Dis 13:1053-1060.
14. Horoszewicz JS, Leong SS, Kawinski K, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostate carcinoma. Cancer Res 43:1809-1818.
15. Isaacs WB, Carter BS (1994) Genetic changes associated with prostate cancer in humans. Prostate Cancer: Cell and molecular mechanisms in diagnosis and treatment. Ed. Franks LM, Cold Spring Harbor Press.
16. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23.
17. Lee W-H, Shew J-H, Hong FD, Sery TW, Donoso LA, Young L-J, Bookstein R, Lee EY-HP (1987) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642-645.
18. Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA (1990) The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396.
19. Mori N, Yokata J, Akiyama T, Sameshima Y, Okamoto A, Mizoguchi H, Toyoshima K, Sugimura T, Terada M (1990) Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene 5:1713-1717.
20. Naylor SL, Sakaguchi AY, Shows TB, Law ML, Goeddel DV, Gray PW (1983) Human immune interferon gene is located on chromosome 12. J Exp Medicine 157:1020-1027.
21. Ning H, Oreffo VIC, Gumerlock PH, Witschi H (1991) Increased c-Ki-ras expression in hamster lung exposed to N-nitrosodiethylamine and hyperoxia as detected by the polymerase chain reaction. Cancer Let 59:75-80.
22. Orkin SH, Kazazian Jr HH (1984) The human beta-globin gene. Ann Rev Genet 18:131-171.
23. Phillips SMA, Barton CM, Lee SJ, Morton DG, Wallace DMA, Lemoine NR, Neoptolemos JP (1994) Loss of the retinoblastoma susceptibility gene (RBI) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 70:1252-1257.
24. Reissman PT, Simon MA, Lee W-H, Slamon DJ (1989) Studies of the retinoblastoma gene in human sarcoma. Oncogene 4:839-843.
25. Sarkar FH, Sakr W, Li Y-W, Macoska J, Ball DE, Crissman JD (1992) Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 21:145-152.
26. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line. Int J Cancer 21:274-281.
27. Thompson TC (1990) Growth factors and oncogenes in prostate cancer. Cancer Cells 2:345-354.
28. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli N, Bell GI, Shows TB (1986) Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 46:6169-6173.
29. Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BAJ, T'Ang A, Fung Y-KT, Brammar WJ, Walker RA (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4:725-727.